08045804946
Send Inquiry
MAKENZA 40MG CAPS
1600.0 INR/Number
Product Details:
- Packaging Type Box
- Pacakaging (Quantity Per Box) 112 capsules per box
- Dosage Form Capsule
- Indication Metastatic castration-resistant prostate cancer
- Life Span 24 months from the date of manufacture
- Salt Composition Enzalutamide
- Brand Name MAKENZA
- Click to View more
X
MAKENZA 40MG CAPS Price And Quantity
- 1600.0 INR/Number
- 1 Number
- Yes
- 1 box
- Not suitable for use in women and children
- Opaque white cap and body
- Fatigue, hot flush, hypertension, headache
- Oral
- Available upon request
- Approved by relevant authorities in country of sale
MAKENZA 40MG CAPS Product Specifications
- Capsule
- Take orally at the same time each day, with or without food
- Box
- 112 capsules per box
- As prescribed by physician, typically 160mg once daily
- Capsule
- Androgen receptor inhibitor for prostate cancer treatment
- Metastatic castration-resistant prostate cancer
- Store below 25C in a dry place, away from light and moisture
- 4 x 28 capsules
- Enzalutamide 40mg
- Adults with metastatic castration-resistant prostate cancer (mCRPC)
- Enzalutamide
- Prescription medicine
- 24 months from the date of manufacture
- Men aged 18 years and above
- MAKENZA
- Yes
- 1 box
- Not suitable for use in women and children
- Opaque white cap and body
- Fatigue, hot flush, hypertension, headache
- Oral
- Available upon request
- Approved by relevant authorities in country of sale
MAKENZA 40MG CAPS Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Asia, Eastern Europe, Middle East, Central America, South America, Australia, North America, Western Europe, Africa
- All India
Product Description
Makenza 40 is available as capsules and works by interfering with the hormones that facilitate cancer growth.
- Active Ingredient: The primary active ingredient is Enzalutamide. Some sources indicate it might contain Everolimus as an active ingredient, so the exact composition depends on the specific formulation and manufacturer.
- Mechanism of Action: It acts as an androgen receptor inhibitor, which means it blocks the effects of male hormones like testosterone that prostate cancer cells need to grow. This action helps to slow down the progression of the cancer.
- Primary Use: It is primarily prescribed for the treatment of prostate cancer that is castration-resistant (cancer that has stopped responding to other treatments that lower testosterone levels). It can be used for both metastatic (spread to other parts of the body) and non-metastatic forms of this cancer.
Important Considerations
- Prescription Drug: Makenza 40 is a prescription medicine and should be used only under the strict guidance and advice of a medical professional.
- Potential Side Effects: Common side effects can vary depending on the active ingredient, but may include headache, dizziness, fatigue, and high blood pressure. Enzalutamide, specifically, can rarely increase the risk of seizures.
- Safety: Do not engage in self-medication. Consult with a doctor or pharmacist before taking this or any other medication to ensure it is safe and appropriate for your condition.
Designed for Advanced Prostate Cancer Management
MAKENZA 40MG CAPS offers a targeted treatment for adults diagnosed with metastatic castration-resistant prostate cancer. With the active ingredient Enzalutamide, it helps disrupt the cancer's progression by inhibiting androgen receptors, crucial for tumor growth. This medication is utilized under strict medical supervision, ensuring an effective, patient-centered approach for eligible men.
Simple Oral Administration and Flexible Dosage
Designed for oral use, each capsule can be taken with or without food, making it easy to integrate into daily routines. Patients typically follow a physician-prescribed regimen, often 160mg once daily, for sustained efficacy. Capsules are packaged for convenience, providing a 28-day supply in each box.
Approved Quality and Safety Standards
MAKENZA 40MG CAPS is approved by local regulatory authorities, ensuring its safety and efficacy for intended users. Each batch is manufactured, packaged, and distributed in compliance with stringent industry standards, offering peace of mind regarding quality and traceability for healthcare providers and patients alike.
FAQ's of MAKENZA 40MG CAPS:
Q: How should MAKENZA 40MG CAPS be taken for optimal results?
A: MAKENZA 40MG CAPS should be taken orally at the same time each day, with or without food, as prescribed by your physician. Strict adherence to the recommended dosage regimen, typically 160mg once daily, is important for effective treatment.Q: What are the potential benefits of using MAKENZA for prostate cancer?
A: MAKENZA contains Enzalutamide, an androgen receptor inhibitor that helps slow the progression of metastatic castration-resistant prostate cancer in adult men, potentially improving disease management and extending progression-free survival.Q: When should I consult my doctor regarding MAKENZA side effects?
A: You should notify your physician immediately if you experience side effects such as fatigue, hot flushes, hypertension, or headaches. Regular monitoring during treatment will help manage and mitigate any undesirable effects.Q: Where should MAKENZA 40MG CAPS be stored to maintain efficacy?
A: Store the capsules below 25C in a dry place, away from light and moisture. Keep the product in its original packaging and out of reach of children.Q: What is the minimum order quantity for MAKENZA 40MG CAPS?
A: The minimum order quantity for MAKENZA 40MG CAPS is one box, containing 112 capsules (enough for a 28-day supply at the usual dose).Q: Who is eligible to use MAKENZA 40MG CAPS?
A: MAKENZA is recommended for adult men aged 18 years and above with metastatic castration-resistant prostate cancer. It is not suitable for use in women or children.Q: What should I do if I miss a dose of MAKENZA?
A: If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose. Do not take two doses at once. Consult your physician for further guidance.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
